FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model

BACKGROUND: The pathogenesis and clinical features of diabetic cardiomyopathy (DCM) have been well studied in the past decade; however, effective approaches to prevent and treat this disease are limited. Fufang Zhenzhu Tiaozhi (FTZ) formula, a traditional Chinese prescription, is habitually used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lexun, Wu, Huijuan, Deng, Yanyue, Zhang, Shengxi, Wei, Quxing, Yang, Qianqian, Piao, Shenghua, Bei, Weijian, Rong, Xianglu, Guo, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492284/
https://www.ncbi.nlm.nih.gov/pubmed/34621323
http://dx.doi.org/10.1155/2021/5582567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492284/
https://www.ncbi.nlm.nih.gov/pubmed/34621323
http://dx.doi.org/10.1155/2021/5582567

Ejemplares similares